Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2010

01.04.2010 | Breast Oncology

Lymphatic Drainage Patterns from the Treated Breast

verfasst von: Iris M. C. van der Ploeg, Hester S. A. Oldenburg, Emiel J. T. Rutgers, Marie-Jeanne T. F. D. Baas-Vrancken Peeters, Bin B. R. Kroon, Renato A. Valdés Olmos, Omgo E. Nieweg

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Lymphatic drainage patterns from the breast have been described in the past. Drainage may change after treatment of a breast or axilla, and this may have implications for lymphatic mapping. The aim of this study was to determine the lymphatic drainage patterns in breast cancer patients with a previously treated ipsilateral breast.

Methods

Between January 1999 and November 2008, 115 sentinel node procedures were performed in breast cancer patients who had undergone treatment of the ipsilateral breast in the past. Lymphatic drainage patterns were analyzed based on preoperative lymphoscintigraphy and sentinel lymph node biopsy. Patients were divided into subgroups according to their previous treatment.

Results

Sentinel nodes were found in 84% of the patients: in 81 patients (70%) in the axilla, 43 patients (37%) had drainage to more than one site, and in 18 patients (16%) no drainage was detected. The percentage of drainage outside the axilla was higher than in a series of untreated breast cancer patients from our institution (51% versus 33%, P = 0.01). The 16% nonidentification rate was also higher than the 3.1% in patients without previous treatment (P = 0.003). Four patients (3.5%) had lymphatic drainage to the contralateral axilla. Twelve patients (10%) had involved sentinel nodes; these were harvested from the contralateral axilla in two of them. No lymph node recurrences were observed during a median follow-up time of 39 months.

Conclusion

Lymphatic mapping yields a lymph node in 84% of breast cancer patients who have undergone previous treatment of the breast. Nonidentification and extra-axillary nodes are more frequently encountered than in patients without treatment of the breast in the past. The finding of involved nodes suggests that sentinel node biopsy improves staging. Long-term follow-up will determine the sensitivity of the procedure in this specific situation.
Literatur
1.
Zurück zum Zitat Sobin LH, Wittekind C, editors. TNM Classification of malignant tumours. Sixth edition. New York: Wiley; 2002. Sobin LH, Wittekind C, editors. TNM Classification of malignant tumours. Sixth edition. New York: Wiley; 2002.
2.
Zurück zum Zitat Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.PubMedCrossRef Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.PubMedCrossRef
3.
Zurück zum Zitat Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608–14.CrossRefPubMed Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608–14.CrossRefPubMed
4.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–53.CrossRefPubMed Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–53.CrossRefPubMed
5.
Zurück zum Zitat Nieweg OE, Estourgie SH, Valdés Olmos RA, et al. Lymphatic mapping with tracer administration into the primary breast cancer. Eur J Surg Oncol. 2003;29:95–7.CrossRefPubMed Nieweg OE, Estourgie SH, Valdés Olmos RA, et al. Lymphatic mapping with tracer administration into the primary breast cancer. Eur J Surg Oncol. 2003;29:95–7.CrossRefPubMed
6.
Zurück zum Zitat Estourgie SH, Nieweg OE, Valdés Olmos RA, et al. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239:232–7.CrossRefPubMed Estourgie SH, Nieweg OE, Valdés Olmos RA, et al. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239:232–7.CrossRefPubMed
7.
Zurück zum Zitat Van der Ploeg IMC, Kroon BBR, Antonini N, et al. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. Ann Surg Oncol. 2008;15:1025–31.CrossRefPubMed Van der Ploeg IMC, Kroon BBR, Antonini N, et al. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. Ann Surg Oncol. 2008;15:1025–31.CrossRefPubMed
8.
Zurück zum Zitat Van Rijk MC, Tanis PJ, Nieweg OE, et al. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol. 2006;94:281–6.CrossRefPubMed Van Rijk MC, Tanis PJ, Nieweg OE, et al. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol. 2006;94:281–6.CrossRefPubMed
9.
Zurück zum Zitat Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141–9.CrossRefPubMed Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141–9.CrossRefPubMed
10.
Zurück zum Zitat Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.CrossRefPubMed Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.CrossRefPubMed
11.
Zurück zum Zitat Osborne MP, Simmons RM. Salvage surgery for recurrence after breast conservation. World J Surg. 1994;18:93–7.CrossRefPubMed Osborne MP, Simmons RM. Salvage surgery for recurrence after breast conservation. World J Surg. 1994;18:93–7.CrossRefPubMed
12.
Zurück zum Zitat Margolese RG. Surgical considerations for invasive breast cancer. Surg Clin North Am. 1999;79:1031–46.CrossRefPubMed Margolese RG. Surgical considerations for invasive breast cancer. Surg Clin North Am. 1999;79:1031–46.CrossRefPubMed
13.
Zurück zum Zitat Perre CI, Hoefnagel CA, Kroon BBR, et al. Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg. 1996;83:1258.CrossRefPubMed Perre CI, Hoefnagel CA, Kroon BBR, et al. Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg. 1996;83:1258.CrossRefPubMed
14.
Zurück zum Zitat Estourgie SH, Valdés Olmos RA, Nieweg OE. Reproducibility of sentinel node lymphoscintigraphy after excisional biopsy of breast lesions. Eur J Nucl Med Mol Imaging. 2004;31:296. Estourgie SH, Valdés Olmos RA, Nieweg OE. Reproducibility of sentinel node lymphoscintigraphy after excisional biopsy of breast lesions. Eur J Nucl Med Mol Imaging. 2004;31:296.
15.
Zurück zum Zitat Koizumi M, Koyama M, Tada K, et al. The feasibility of sentinel node biopsy in the previously treated breast. Eur J Surg Oncol. 2008;34:365–8.PubMed Koizumi M, Koyama M, Tada K, et al. The feasibility of sentinel node biopsy in the previously treated breast. Eur J Surg Oncol. 2008;34:365–8.PubMed
16.
Zurück zum Zitat Port ER, Garcia-Etienne CA, Park J, et al. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol. 2007;14:2209–14.CrossRefPubMed Port ER, Garcia-Etienne CA, Park J, et al. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol. 2007;14:2209–14.CrossRefPubMed
17.
Zurück zum Zitat Roumen RM, Kuijt GP, Liem IH. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol. 2006;32:1076–81.CrossRefPubMed Roumen RM, Kuijt GP, Liem IH. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol. 2006;32:1076–81.CrossRefPubMed
18.
Zurück zum Zitat Taback B, Nguyen P, Hansen N, et al. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol. 2006;13:1099–104.CrossRefPubMed Taback B, Nguyen P, Hansen N, et al. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol. 2006;13:1099–104.CrossRefPubMed
19.
Zurück zum Zitat Nieweg OE, Tanis PJ, Kroon BBR. The definition of a sentinel node. Ann Surg Oncol. 2001;8:538–41.CrossRefPubMed Nieweg OE, Tanis PJ, Kroon BBR. The definition of a sentinel node. Ann Surg Oncol. 2001;8:538–41.CrossRefPubMed
20.
Zurück zum Zitat Van der Ploeg IMC, Valdés Olmos RA, Nieweg OE, et al. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med. 2007;48:1756–60.CrossRefPubMed Van der Ploeg IMC, Valdés Olmos RA, Nieweg OE, et al. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med. 2007;48:1756–60.CrossRefPubMed
21.
Zurück zum Zitat Axelsson CK, Jonsson PE. Sentinel lymph node biopsy in operations for recurrent breast cancer. Eur J Surg Oncol. 2008;34:626–30.PubMed Axelsson CK, Jonsson PE. Sentinel lymph node biopsy in operations for recurrent breast cancer. Eur J Surg Oncol. 2008;34:626–30.PubMed
22.
Zurück zum Zitat Boughey JC, Ross MI, Babiera GV, et al. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer. 2006;7:248–53.CrossRefPubMed Boughey JC, Ross MI, Babiera GV, et al. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer. 2006;7:248–53.CrossRefPubMed
23.
Zurück zum Zitat Intra M, Trifiro G, Viale G, et al. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol. 2005;12:895–9.CrossRefPubMed Intra M, Trifiro G, Viale G, et al. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol. 2005;12:895–9.CrossRefPubMed
24.
Zurück zum Zitat Luini A, Galimberti V, Gatti G, et al. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat. 2005;89:159–63.CrossRefPubMed Luini A, Galimberti V, Gatti G, et al. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat. 2005;89:159–63.CrossRefPubMed
25.
Zurück zum Zitat Newman EA, Cimmino VM, Sabel MS, et al. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol. 2006;13:52–7.CrossRefPubMed Newman EA, Cimmino VM, Sabel MS, et al. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol. 2006;13:52–7.CrossRefPubMed
26.
Zurück zum Zitat American Joint Committee on Cancer: AJCC cancer staging manual, version 01.03.00. Philadelphia, PA: Lippincott-Raven; 2006. American Joint Committee on Cancer: AJCC cancer staging manual, version 01.03.00. Philadelphia, PA: Lippincott-Raven; 2006.
27.
Zurück zum Zitat Sood A, Youssef IM, Heiba SI, et al. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med. 2004;29:698–702.CrossRefPubMed Sood A, Youssef IM, Heiba SI, et al. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med. 2004;29:698–702.CrossRefPubMed
28.
Zurück zum Zitat Van der Ploeg IMC, Nieweg OE, Van Rijk MC, et al. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol. 2008;34:1277–84.PubMed Van der Ploeg IMC, Nieweg OE, Van Rijk MC, et al. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol. 2008;34:1277–84.PubMed
29.
Zurück zum Zitat Estourgie SH, Valdés Olmos RA, Nieweg OE, et al. Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg. 2007;94:1088–91.CrossRefPubMed Estourgie SH, Valdés Olmos RA, Nieweg OE, et al. Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg. 2007;94:1088–91.CrossRefPubMed
30.
Zurück zum Zitat Wright FC, Walker J, Law CH, et al. Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol. 2003;10:1054–8.CrossRefPubMed Wright FC, Walker J, Law CH, et al. Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol. 2003;10:1054–8.CrossRefPubMed
Metadaten
Titel
Lymphatic Drainage Patterns from the Treated Breast
verfasst von
Iris M. C. van der Ploeg
Hester S. A. Oldenburg
Emiel J. T. Rutgers
Marie-Jeanne T. F. D. Baas-Vrancken Peeters
Bin B. R. Kroon
Renato A. Valdés Olmos
Omgo E. Nieweg
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0841-6

Weitere Artikel der Ausgabe 4/2010

Annals of Surgical Oncology 4/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.